Stockreport

Prelude Therapeutics to Participate in Citizens JMP Life Sciences Conference

Prelude Therapeutics Incorporated  (PRLD) 
PDF WILMINGTON, Del., May 09, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced t [Read more]